Calcium Strontium Phosphate Production Cost Reports

The report provides a detailed analysis essential for establishing a calcium strontium phosphate production plant. It encompasses all critical aspects necessary for calcium strontium phosphate production, including the cost of calcium strontium phosphate production, calcium strontium phosphate plant cost, calcium strontium phosphate production costs, and the overall calcium strontium phosphate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a calcium strontium phosphate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Calcium strontium phosphate is a modified form of calcium phosphate doped with strontium ions, and finds its industrial applications in the biomedical sector, mainly for bone regeneration and orthopaedic implants. It is used in bone cements, scaffolds, and coatings that enhance osseointegration by promoting osteoblast activity while inhibiting osteoclast resorption, due to strontium's dual anabolic and anti-catabolic effects on bone tissue.

These materials are incorporated into dental implants, joint replacements, and defect-filling grafts to offer improved mechanical strength, up to 53 MPa compressive strength in some formulations, and radiographic visibility for surgical precision. Additionally, its non-biomedical uses include agriculture as a fertiliser component to boost soil nutrient availability and crop yields, as well as corrosion-resistant coatings for magnesium-based implants.

Calcium strontium phosphate's market growth is driven by surging demand in the medical and dental sectors for bone grafts, implants, and cements due to its biocompatibility and bone regeneration properties. An ageing global population boosts needs for orthopaedic solutions, amid rising osteoporosis and fractures.

The rising orthopaedic implants market, as well as the growing cosmetic dentistry, fuelled by aesthetic procedures using the compound, boosts the market growth. Ongoing biomaterials R&D enhances bioactivity and mechanical strength, spurring adoption in regenerative medicine and tissue engineering through advanced synthesis like ion doping also contributes to the market demand. However, raw material price volatility and phosphate mining environmental concerns impact industrial calcium strontium phosphate procurement.

Raw Material for Calcium Strontium Phosphate Production

According to the calcium strontium phosphate production plant project report, the various raw materials for calcium strontium phosphate production include calcium hydrogen phosphate, calcium carbonate, strontium carbonate, and ammonium dihydrogen phosphate.

Production Process of Calcium Strontium Phosphate

The extensive calcium strontium phosphate production cost report consists of the following major industrial production process:

1. Production via high-pressure high-temperature synthesis: The production process for calcium strontium phosphate involves a two-step high-pressure, high-temperature synthesis. In the first step, stoichiometric mixtures of reagent-grade calcium hydrogen phosphate, calcium carbonate, strontium carbonate, and ammonium dihydrogen phosphate powders are ground for 2 hours in an agate mortar. In the next step, the mixture is pressed into 7 mm diameter pellets under 30 MPa uniaxial pressure and heated at elevated temperatures. Finally, these pellets are subjected to 7 GPa pressure and 1473 K to produce calcium strontium phosphate.

Properties of Calcium Strontium Phosphate

Calcium strontium phosphate, often as strontium-substituted hydroxyapatite (Sr-HA) or tricalcium phosphate (Sr-TCP), appears as a white amorphous or crystalline powder form. It has a density around 3.1-4.5 g/cm³ (higher with Sr content), high melting point near 1,600-1,670 °C, and low water solubility (Ksp ~10^-25 to 10-²⁸), though Sr doping increases solubility due to lattice destabilisation from its larger ionic radius (0.118 nm vs. Ca's 0.100 nm). It has a hexagonal or orthorhombic lattice with linear unit cell expansion upon Sr substitution, shifting phosphate (PO4³^-) vibrational bands to lower wavenumbers in FTIR/Raman spectra (e.g., ν1 at ~960 cm^-¹, ν3 at ~1,000-1,100 cm^-¹). It also has enhanced thermal stability, β-TCP form persists beyond 1,125 °C with Sr stabilisation. It reacts with acids to form soluble phosphates, shows bioresorbability modulated by Sr content (e.g., (Ca+Sr)/P ratio ~1.67-2.0), and displays antimicrobial effects in nanoforms, with Ca/Sr-O bond lengths elongated (e.g., 2.4-2.7 Å), promoting bioactivity for bone applications.